APA (7th ed.) Citation

L, O., DA, H., ES, P., GL, W., CT, M., NR, L., . . . KM, A. (2025). Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9. Journal of controlled release : official journal of the Controlled Release Society, 384, 113855. https://doi.org/10.1016/j.jconrel.2025.113855

Chicago Style (17th ed.) Citation

L, Ontiveros-Padilla, et al. "Broadly Active Intranasal Influenza Vaccine with a Nanocomplex Particulate Adjuvant Targeting Mast Cells and Toll-like Receptor 9." Journal of Controlled Release : Official Journal of the Controlled Release Society 384 (2025): 113855. https://doi.org/10.1016/j.jconrel.2025.113855.

MLA (9th ed.) Citation

L, Ontiveros-Padilla, et al. "Broadly Active Intranasal Influenza Vaccine with a Nanocomplex Particulate Adjuvant Targeting Mast Cells and Toll-like Receptor 9." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 384, 2025, p. 113855, https://doi.org/10.1016/j.jconrel.2025.113855.

Warning: These citations may not always be 100% accurate.